TipRanks
iX Biopharma Ltd. (SG:42C)
SGX:42C
Singapore Market
42C
iX Biopharma Ltd.
RESEARCH TOOLSreports
Want to see SG:42C full AI Analyst Report?

iX Biopharma Ltd. (42C) Income Statement

25 Followers

iX Biopharma Ltd. Income Statement

Last quarter (Q4 2025), iX Biopharma Ltd.'s total revenue was S$5.26M, an increase of 60.15% from the same quarter last year. In Q4, iX Biopharma Ltd.'s net income was S$-7.08M. See iX Biopharma Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
S$ 6.85MS$ 7.77MS$ 5.96MS$ 5.91MS$ 14.39M
Gross Profit
S$ 2.43MS$ 2.04MS$ 1.05MS$ 2.32MS$ 12.29M
Operating Expenses
S$ 11.99MS$ 8.32MS$ 8.44MS$ 10.73MS$ 11.05M
Depreciation and Amortization
S$ 728.00KS$ 854.00KS$ 868.00KS$ 929.00KS$ 1.06M
EBITDA
S$ -8.83MS$ -8.96MS$ -8.68MS$ -8.51MS$ -2.84M
Operating Income
S$ -9.56MS$ -6.29MS$ -7.39MS$ -8.41MS$ 1.24M
Other Income/Expenses
S$ 1.58MS$ -3.85MS$ -2.60MS$ -1.29MS$ -5.34M
Pretax Income
S$ -7.98MS$ -10.14MS$ -9.98MS$ -9.71MS$ -4.10M
Net Income
S$ -7.99MS$ -10.14MS$ -10.79MS$ -9.62MS$ -4.60M
Per Share Metrics
Basic EPS
S$ >-0.01S$ -0.01S$ -0.01S$ -0.01S$ -0.01
Diluted EPS
S$ >-0.01S$ -0.01S$ -0.01S$ -0.01S$ -0.01
Weighted Average Shares Outstanding
 965.01M 874.22M 767.36M 764.85M 754.63M
Weighted Average Shares Outstanding (Diluted)
 965.01M 876.68M 767.36M 764.85M 754.63M
Currency in SGD

iX Biopharma Ltd. Earnings and Revenue History